Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemia

被引:27
作者
Mondal, BC
Paria, N
Majumdar, S
Chandra, S
Mukhopadhyay, A
Chaudhuri, U
Dasgupta, UB
机构
[1] Univ Calcutta, Dept Biophys Mol Biol & Genet, Kolkata 700009, W Bengal, India
[2] Subodh Mitra Canc Hosp & Res Ctr, Kolkata, India
关键词
CML; GST M1; GST T1; null genotype;
D O I
10.1097/00008469-200506000-00014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Polymorphisms associated with genes coding for glutathione S-transferase enzymes are known to influence metabolism of different carcinogens and have been associated with incidence of various types of cancer. We have determined the GST M1 and GST T1 'null' genotype frequency in 81 patients with chronic myeloid leukaemia (CML) and 123 racially and geographically matched control individuals by multiplex polymerase chain reaction (PCR). GST M1 null genotype frequencies in CML and controls were 28.4% and 27.7%, respectively. GST T1 null genotype frequencies in CML and controls were 19.8% and Z3%, respectively. The GST T1 null genotype frequency in CML patients is significantly different from that in controls (odds ratio (OR) 3.12, 95% confidence interval (Cl) 1.3-7.45, P=0.008). (c) 2005 Lippincott Williams & Wilkins.
引用
收藏
页码:281 / 284
页数:4
相关论文
共 18 条
[1]  
ARMUDA VR, 2001, EUR J HAEMATOL, V66, P383
[2]   Major beta-globin gene mutations in eastern India and their associated haplotypes [J].
Bandyopadhyay, A ;
Bandyopadhyay, S ;
Chowdhury, MD ;
Dasgupta, UB .
HUMAN HEREDITY, 1999, 49 (04) :232-235
[3]   Statistics notes - The odds ratio [J].
Bland, JM ;
Altman, DG .
BRITISH MEDICAL JOURNAL, 2000, 320 (7247) :1468-1468
[4]   Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect [J].
Chen, HW ;
Sandler, DP ;
Taylor, JA ;
Shore, DL ;
Liu, E ;
Bloomfield, CD ;
Bell, DA .
LANCET, 1996, 347 (8997) :295-297
[5]   Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia [J].
Davies, SM ;
Bhatia, S ;
Ross, JA ;
Kiffmeyer, WR ;
Gaynon, PS ;
Radloff, GA ;
Robison, LL ;
Perentesis, JP .
BLOOD, 2002, 100 (01) :67-71
[6]  
HALL AG, 1994, CANCER RES, V54, P5251
[7]  
Howells REJ, 1998, CLIN CANCER RES, V4, P2439
[8]   Susceptibility to childhood acute lymphoblastic leukemia: Influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms [J].
Krajinovic, M ;
Labuda, D ;
Richer, C ;
Karimi, S ;
Sinnett, D .
BLOOD, 1999, 93 (05) :1496-1501
[9]   Mammalian class theta GST and differential susceptibility to carcinogens: a review [J].
Landi, S .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2000, 463 (03) :247-283
[10]   Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias [J].
Lemos, MC ;
Cabrita, FJ ;
Silva, HA ;
Vivan, M ;
Plácido, F ;
Regateiro, FJ .
CARCINOGENESIS, 1999, 20 (07) :1225-1229